Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AstraZeneca Sets Up Industrial Park In Shanghai

This article was originally published in PharmAsia News

Executive Summary

AstraZeneca is planning to increase its investment in China by establishing an AstraZeneca industrial park in Shanghai. It will be a comprehensive center that combines highly efficient management activities, advanced R&D facilities and first-class training amenities. The project, which has started, will be completed by 2010. AstraZeneca's 2007 annual report showed that the company achieved $500 million sales in China (including Hong Kong), an increase of 25 percent over the previous year, even while its global profit decreased by 7.2 percent. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts